What do you mean when you say a planned S3 won't help? tia

Well, I finally moved more money into my account (half the battle lol). Now all I've got left to do is pull the trigger. It's always hard getting past the butterflies initially. :) :) :)

But when I do, I take another 149,900 shares.

Go PharmaCyte!!!!!!!!!!

I continue to hope that indeed it's Janssen planning and preparing to utilize CiaB therapy in multiple options.

Agree :) :) :)

Hey Rudy, good morning! I notice that recently you've been posting more about diabetes and hardly anything on PC.

I realize things are looking up for PMCB and we are all excited, but aren't you getting a little ahead of yourself? :) :) :)

Don't jinx us! lol ;)

Be nice to have an agreement with at least one of the remaining provinces.

New Brunswick 753,914 (Organigram and Canopy)

British Columbia 4.631 million

Manitoba 1.282 million

Nova Scotia 942,926

Newfoundland and Labrador 528,448

Ontario 13.6 million

Prince Edward Island 146,283

Québec 8.215 million

Saskatchewan 1.13 million

Alberta 4.146 million

I
LO
VE
DINAFEM!!!!!!

It certainly establishes the case for needing CiaB therapy.

Love you all, but I will have to add that when it comes to knowledge, Rudy sure does shine. :) :) :)

Thank you much Rudy for all of your in-depth explanations.

I wouldn't say that. Instead, I would praise their amazing ability to dig up information (most with links). There are some great hounds here, but Trip and Brian beats all of I've ever seen. :) :) :)

Go PharmaCyte!!!

That post is greatly appreciated Trip! :) :) :)

Indeed! ...for good reason.

That goes for me as well. :) :) :)

Things are getting good, but stinks at the same time.

I'm itching to pull the trigger on more shares, but then again, I wanna just remain cautiously optimistic and stay the course with what I have.

I invite anyone to defend my last comment about the executives, and please, elaborate.

Further dilution is certainly possible now having that many on the shelf.

I guess it just depends on when they're used.

Regarding the R/S, I think it's inevitable.

I always hated the fact knowing none of the executives ever spent their own personal cash to buy shares...never. Not even now, at our own inflection point.

What if things actually do go well with the IND and the trial and a buyout happens?

I don't think we would need Morell, for a hand full of reasons actually.

But what if a partnership happens?

Then, we would most certainly need to have our own IR in place.

I've always thought a partnership to build value was best for all. jmo

I wildly agree with you Trip. And what I think I see playing out with a possible partnership, or buyout, is PharmaCyte preparing (just in case) for an uplist.

I've read where a reverse split normally coincides with an offering to a third-party.

4+ million dollars and no debt makes for a decent balance sheet, along with a reverse split to get the capital structure in line, all makes sense.

Make things right for the suiter. :) :) :)

Go PharmaCyte!!!

??? ...Q4 hasn't even started yet.

I just found this interesting Harvard piece that may help those of you who are disappointed with Mr. Waggoner. Perhaps an insight to his reasoning can be found (or not) within these excerpts.

....Taking responsibility for something one is incapable of doing has never been a particularly good idea. Politicians get in trouble for promising their electorates that they can fix the economy when they can’t. Money managers get in trouble when they tell their clients that they will beat the market when they can’t. The only thing of which we can be sure is that in due course the promise-taker will be disappointed and the promise-giver will be frustrated. And in due course, disappointment and frustration turns to anger and recrimination for both sides.

....This same sad story plays out between modern CEOs and their shareholders. CEOs promise that they will increase their ‘shareholder value’ and dedicate themselves to that task. But shareholder value increases only when expectations of future performance increase from its current level and no CEO can keep their company marching ahead of expectations forever.

....Trying to raise expectations indefinitely is not only impossible, it’s positively damaging. CEOs saddled with high expectations feel compelled to take risky actions to try to do the impossible in order to generate still more overblown expectations. CEOs who are the beneficiary of low expectations will take shareholders to the cleaners by making boatloads of stock-based compensation by simply hanging around and waiting for expectations to float up to their natural level.

....CEOs strive to increase shareholder value because they think it is the right thing to do (their moral obligation) and are reinforced in this belief by their boards that provide them incentives for doing just that. It isn’t ‘the right thing to do’ and boards shouldn’t encourage them to think it is. The fact is, despite their belief to the contrary, neither boards nor management actually owe public shareholders an attractive return on the market value of the stock they purchased.

....The fallacy is that CEOs think that they have an obligation to earn an attractive return for shareholders who purchased their shares from an existing shareholder at above the price at which those shares were sold out of the corporate treasury. The only shareholder to whom the CEO owes anything is the shareholder who provided capital to the company. That shareholder deserves a return at the cost of equity on that initial investment.

....In the long run, companies would be healthier and their shareholders better off if their CEOs only sought to earn a return on the capital provided to them by shareholders, i.e. their book capital not their market capital. Enshrining that in the mission statements of America’s corporations would be a great place to start.

Good night all.

Go PharmaCyte!!!

Best of luck!!! :)

Hey MADD sorry to hear that, where are you at?

Need a little more time to think about it.

Go PharmaCyte!!!!!!

Yes we may begin to see results that quick, ...however, they will wait for "maximum response" of the treatment ...that will still take the 4 to 6 months as PMCB stated.

Sorry Mick, I was just questioning the redundancy.

Have a good weekend. :)

Tkanks efood :)

Thank you for that input Triple9

That's a good post, but do you have any idea as to "how it's worked out"? ...have you had stocks or know of any where this situation, or similar, has happened before?

Triple9, do you think the IND submission and exceptance, along with positive results at the six-month stop, will be enough to take us past the one dollar mark?, or do you think it will ultimately take a partnership (or buyout) announcement to get us there?

Glad to know that, very helpful...thank you! ;)

Triple9, I just mentioned that because you had mentioned the institutions again as buying.

Every time someone post anything "mentioning" the "institutional buying" they never mention the possibility of those buys being done by individual investors via the institution. Thats all. :) ...no harm.

Just trying to be helpful.

I'm still guessing they were probably bought by individual investors via the institution.

I only say it's possible because supposedly a handful of you here own millions and millions of shares, each. Right, Pete?

Nevertheless, those buys help. :) :) :)

Lets go PharmaCyte!

Actually, its good to still see this post. :)

https://m.facebook.com/austrianova/posts/1616942591670942

Actually, the Facebook postings were up before the agreement PR so it does make sense. :) :) :)

Nah... it will still be a little while.

As for the stripping of the FB post, perhaps they were told to take them down. It is both interesting and exciting. Boils the speculation. :) :) :)

However, if this is all one big fantastic head fake, it would certainly go down in history as one of the stock market's biggest. (crazy thought)

He is actually one of the negotiators of the term sheet agreement that made you eat crow.

Yes, I thought that was the case once Mr. Waggoner posted his Canadians remark on his Facebook page. ;)

Well, I actually hope there's enough positive news before, during, and after the IND to push us into dollar land so that a reverse split isn't necessary.

Best case scenario (for me), is a partnership announcement is made after a successful IND submission that attracts enough investors to blast us through that $1 milestone. ;)

One thing is for certain, the only thing that will execute a partnership or buyout agreement (and immediately I don't prefer the latter) to is positive results.

So, come on team!!!, come on CiaB!!!, ...BRING IT!!!!!

Good morning efood, yesterday I meant that I was suspicious to his post, not the agreement. Today however, I believe things are much clearer for both he and I ...or at least it is for me. :) :) :) Go PharmaCyte!

At the end of the day you should rather feel like a stuffed pig rather than a slaughtered hog. :) :) :)